These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 10992004)
61. In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action. Lehtimäki J; Leino T; Koivisto A; Viitamaa T; Lehtimäki T; Haapalinna A; Kuokkanen K; Virtanen R Eur J Pharmacol; 2008 Dec; 599(1-3):65-71. PubMed ID: 18930723 [TBL] [Abstract][Full Text] [Related]
62. Synthesis and pharmacological characterization of a novel, highly potent, peptidomimetic delta-opioid radioantagonist, [3H]Tyr-Tic-(2S,3R)-beta-MePhe-Phe-OH. Birkas E; Kertesz I; Toth G; Bakota L; Gulya K; Szucs M Neuropeptides; 2008 Feb; 42(1):57-67. PubMed ID: 18068762 [TBL] [Abstract][Full Text] [Related]
63. NK(3) receptor agonism promotes episodic-like memory in mice. Zlomuzica A; Dere E; Huston JP; de Souza Silva MA Neurobiol Learn Mem; 2008 Sep; 90(2):420-5. PubMed ID: 18556225 [TBL] [Abstract][Full Text] [Related]
64. Central injection of senktide, an NK3 receptor agonist, or neuropeptide Y inhibits LH secretion and induces different patterns of Fos expression in the rat hypothalamus. Sandoval-Guzmán T; Rance NE Brain Res; 2004 Nov; 1026(2):307-12. PubMed ID: 15488494 [TBL] [Abstract][Full Text] [Related]
65. Involvement of the central tachykinin NK1 receptor during maintenance of mechanical hypersensitivity induced by diabetes in the rat. Field MJ; McCleary S; Boden P; Suman-Chauhan N; Hughes J; Singh L J Pharmacol Exp Ther; 1998 Jun; 285(3):1226-32. PubMed ID: 9618426 [TBL] [Abstract][Full Text] [Related]
66. NK-3 receptors mediate enhancement of substance P release from capsaicin-sensitive spinal cord afferent terminals. Schmid G; Carità F; Bonanno G; Raiteri M Br J Pharmacol; 1998 Oct; 125(4):621-6. PubMed ID: 9831894 [TBL] [Abstract][Full Text] [Related]
72. Molecular and pharmacological characterization of a functional tachykinin NK3 receptor cloned from the rabbit iris sphincter muscle. Medhurst AD; Hirst WD; Jerman JC; Meakin J; Roberts JC; Testa T; Smart D Br J Pharmacol; 1999 Oct; 128(3):627-36. PubMed ID: 10516642 [TBL] [Abstract][Full Text] [Related]
73. A novel role for tachykinin neurokinin-3 receptors in regulation of human bronchial Ganglia neurons. Myers AC; Goldie RG; Hay DW Am J Respir Crit Care Med; 2005 Feb; 171(3):212-6. PubMed ID: 15477495 [TBL] [Abstract][Full Text] [Related]
74. Functional expression of a novel human neurokinin-3 receptor homolog that binds [3H]senktide and [125I-MePhe7]neurokinin B, and is responsive to tachykinin peptide agonists. Krause JE; Staveteig PT; Mentzer JN; Schmidt SK; Tucker JB; Brodbeck RM; Bu JY; Karpitskiy VV Proc Natl Acad Sci U S A; 1997 Jan; 94(1):310-5. PubMed ID: 8990205 [TBL] [Abstract][Full Text] [Related]
76. AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor. Griffin BW; Klimko P; Crider JY; Sharif NA J Pharmacol Exp Ther; 1999 Sep; 290(3):1278-84. PubMed ID: 10454504 [TBL] [Abstract][Full Text] [Related]
77. Evidence for modulation of dopamine-neuronal function by tachykinin NK3 receptor stimulation in gerbil mesencephalic cell cultures. Alonso R; Fournier M; Carayon P; Petitpretre G; Le Fur G; Soubrié P Eur J Neurosci; 1996 Apr; 8(4):801-8. PubMed ID: 9081631 [TBL] [Abstract][Full Text] [Related]
78. Substance P regulates PTH secretion through the neurokinin-1 receptor. Galvin RJ; Babbey LE; Hipskind PA; Lamar T; George CA; Baez M; Gitter BD Biochem Biophys Res Commun; 2000 Apr; 270(1):230-4. PubMed ID: 10733932 [TBL] [Abstract][Full Text] [Related]
79. Upregulation of tachykinin NK-1 and NK-3 receptor binding sites in the spinal cord of spontaneously hypertensive rat: impact on the autonomic control of blood pressure. Cloutier F; Ongali B; Deschamps K; Brouillette J; Neugebauer W; Couture R Br J Pharmacol; 2006 May; 148(1):25-38. PubMed ID: 16491095 [TBL] [Abstract][Full Text] [Related]
80. Functional characterization of the nonpeptide neurokinin3 (NK3) receptor antagonist, SR142801 on the human NK3 receptor expressed in Chinese hamster ovary cells. Oury-Donat F; Carayon P; Thurneyssen O; Pailhon V; Emonds-Alt X; Soubrié P; Le Fur G J Pharmacol Exp Ther; 1995 Jul; 274(1):148-54. PubMed ID: 7616392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]